Around 25% of breast cancer survivors develop lymphedema, and their treatment options are extremely limited. Developing improved lymphedema treatments requires an effective phantom of the lymphatic system, to serve as a meaningful testing platform. However, current phantom technology is not appropriate for analyzing lymphedema treatment devices. This project addresses the limitations of phantom technology and will be essential in revolutionizing the state of lymphedema treatment.
← View all Capstone Projects